Active Ingredient: CIPROFLOXACIN
Proprietary Name: CIPRO
Dosage Form; Route of Administration: FOR SUSPENSION; ORAL
Strength: 500MG/5ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N020780
Product Number: 002
Approval Date: Sep 26, 1997
Applicant Holder Full Name: BAYER HEALTHCARE PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information